[ad_1]
Reuters
British company “AstraZeneca” sold its stake in US company “Moderna” for $ 1.2 billion, after the latter rose dramatically in value following its entry into the global Corona vaccine market.
According to a Times report, as part of the deal, AstraZeneca divested its 7.7% stake in Moderna, making it previously the US company’s largest investor.
The newspaper said the deal would allow “AstraZenica” to improve its financial situation, in light of the pharmaceutical giant’s plans to acquire US company Alexion for $ 39 billion.
Shares of the company “Moderna” rose sharply in November, after the company announced that the efficacy of its vaccine had reached 94.5 percent, making it one of the first vaccines to be registered and to begin to be used around the world.
The value of the company’s shares also rose, when the US Food and Drug Administration approved the emergency use of the “Moderna” vaccine against the coronavirus last December, and this was followed by the approval of the European Union and Great Britain.
On February 11, Moderna announced that it would deliver 200 million doses of its vaccine to the United States by May 2021, adding that the company had signed agreements with various countries to provide more than 641 million doses.
Source: “The Times”
[ad_2]
Source link
